Speaker illustration

Doctor Dimitrios Patoulias

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

Member of:

European Society of Cardiology

Sodium-glucose co-transporter-2 inhibitors improve cardiovascular outcomes in heart failure with reduced ejection fraction regardless of ischemic etiology

Event: ESC Congress 2021 - The Digital Experience

Topic: Treatment

Session: Congress committee e-posters choice in heart failure

Thumbnail

Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

Meta-analysis assessing cardiovascular outcomes with febuxostat versus allopurinol for patients with gout

Event: ESC Congress 2021 - The Digital Experience

Topic: Drugs, Drug Targets

Session: Basic science e-posters

Thumbnail

Effect of sodium-glucose co-transporter 2 inhibitors on left ventricular mass and left atrial volume indices assessed either by cardiovascular magnetic resonance or transthoracic echocardiography

Event: ESC Congress 2021 - The Digital Experience

Topic: Morphology, Dimensions, Volumes and Mass

Session: Echocardiography ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb